In a typical phase three oncology trial, an average of 3.6 million data points will be generated, according to recent studies – three times the data collected by late-stage trials 10 years ago!
When each of these data points is copied in manually from another system, then cross-checked manually by up to two other people, it’s easy to see how the time and cost of this process quickly spirals.
Join AstraZeneca’s Mats Sundgren and IgniteData’s Dan Hydes for fresh insights on solving the clinical trial data challenge.
‘Faster and Better’: automating data between Electronic Health Records and Electronic Data Capture systems at hospitals.